Polpharma

Polpharma, established in 1935, is a prominent leader in the pharmaceutical and healthcare sectors. Based in Starogard Gdański, Poland, the company focuses on the development and manufacturing of high-quality pharmaceutical products, including active pharmaceutical ingredients (APIs) and generic drugs. With a long-standing history of innovation, Polpharma maintains a robust presence across Europe and Asia, delivering essential medicinal solutions to global markets.

The organization operates with a workforce of 1,000-5,000 employees across its 2 primary locations. Polpharma leverages advanced SAP systems and Ariba platforms to streamline its complex manufacturing and supply chain operations. Meet Polpharma's team to understand the leadership driving these technical initiatives and the company's commitment to safety and dosage form innovation. Their operational footprint emphasizes green manufacturing practices and contract packaging services to ensure product availability and patient comfort.

Financially, Polpharma demonstrates significant market stability, reporting annual revenue of approximately $1.5B. The company’s growth strategy is supported by strategic capital investments, including a $50.3M debt financing round secured from the European Investment Bank in 2015. Explore financial highlights to review these metrics and the company's ongoing investment in drug development. As a private entity, Polpharma continues to expand its portfolio of generic drugs and medicinal substances, solidifying its position as a champion in the pharmaceutical field.